{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06212791",
            "orgStudyIdInfo": {
                "id": "HM20027087"
            },
            "secondaryIdInfos": [
                {
                    "id": "K23HL166956",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/K23HL166956"
                }
            ],
            "organization": {
                "fullName": "Virginia Commonwealth University",
                "class": "OTHER"
            },
            "briefTitle": "EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation",
            "officialTitle": "EXCLAMATORY: EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation TO Reduce Atrial Fibrillation Burden and Correlation With Exercise CapacitY Longitudinal Study",
            "acronym": "EXCLAMATORY",
            "therapeuticArea": [
                "Other"
            ],
            "study": "exercise-cardiac-magnetic-resonance-assessment-of-left-atrial-mechanics-following-ablation"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-12-30",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-12-19",
            "studyFirstSubmitQcDate": "2024-01-08",
            "studyFirstPostDateStruct": {
                "date": "2024-01-19",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-08",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-19",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Virginia Commonwealth University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Longitudinal, observational cohort study to evaluate changes in left atrial (LA) reservoir function during exercise and overall exertional capacity in patients following catheter ablation for paroxysmal atrial fibrillation (AF).",
            "detailedDescription": "EXCLAMATORY is a longitudinal observational cohort clinical research study to evaluate the effects of catheter ablation for paroxysmal atrial fibrillation on left atrial and left ventricular performance during exercise, as well as effects on overall exercise capacity"
        },
        "conditionsModule": {
            "conditions": [
                "Paroxysmal Atrial Fibrillation"
            ],
            "keywords": [
                "Catheter ablation",
                "Exercise capacity"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Patients under going catheter ablation",
                    "description": "Patients undergoing catheter ablation for paroxysmal AF, reduction or elimination of arrhythmia burden",
                    "interventionNames": [
                        "Behavioral: Self- Report Evaluation-Duke Activity Status Index",
                        "Behavioral: Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire",
                        "Diagnostic Test: Cardiopulmonary exercise test (CPET)",
                        "Diagnostic Test: Transthoracic echocardiogram",
                        "Diagnostic Test: Ambulatory cardiac rhythm assessment",
                        "Diagnostic Test: Cardiovascular magnetic resonance (CMR)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Self- Report Evaluation-Duke Activity Status Index",
                    "description": "Complete the Self- Report Evaluation-Duke Activity Status Index",
                    "armGroupLabels": [
                        "Patients under going catheter ablation"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire",
                    "description": "Complete the Self- Report Evaluation, Atrial Fibrillation Effect on Quality of Life Questionnaire",
                    "armGroupLabels": [
                        "Patients under going catheter ablation"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Cardiopulmonary exercise test (CPET)",
                    "description": "Cardiopulmonary exercise test (CPET)",
                    "armGroupLabels": [
                        "Patients under going catheter ablation"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Transthoracic echocardiogram",
                    "description": "Transthoracic echocardiogram at rest and immediately following peak exercise during CPET",
                    "armGroupLabels": [
                        "Patients under going catheter ablation"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Ambulatory cardiac rhythm assessment",
                    "description": "Ambulatory cardiac rhythm assessment",
                    "armGroupLabels": [
                        "Patients under going catheter ablation"
                    ]
                },
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Cardiovascular magnetic resonance (CMR)",
                    "description": "Cardiovascular magnetic resonance (CMR) study at rest and during two stages of submaximal exercise (ExeCMR)",
                    "armGroupLabels": [
                        "Patients under going catheter ablation"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in LA reservoir function reserve at submaximal exercise after catheter ablation in patients with paroxysmal AF.",
                    "description": "Change in LA reservoir volume reserve from baseline to follow up, change in left ventricular (LV) stroke volume reserve from baseline to follow up, correlation between changes in LA reservoir volume reserve and changes in LV stroke volume reserve. Therefore the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.",
                    "timeFrame": "Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation."
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in LV stroke volume reserve at submaximal exercise after catheter ablation in patients with paroxysmal AF.",
                    "description": "Change in LA reservoir volume reserve from baseline to follow up, change in LV stroke volume reserve from baseline to follow up, correlation between changes in LA reservoir volume reserve and changes in LV stroke volume reserve.",
                    "timeFrame": "Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation."
                },
                {
                    "measure": "Correlation between changes in LA reservoir volume reserve and changes in LV stroke vol reserve after catheter ablation in patients with paroxysmal AF",
                    "description": "Correlation between changes in LA reservoir volume reserve and changes in LV stroke volume reserve after catheter ablation in patients with paroxysmal AF",
                    "timeFrame": "Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation."
                },
                {
                    "measure": "Correlation between changes in LA reservoir function reserve at submaximal exercise and changes in mixed venous oxygen tension (pVO2) .",
                    "description": "Correlation between changes in LA reservoir function reserve at submaximal exercise and changes in pVO2 after catheter ablation",
                    "timeFrame": "Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation."
                },
                {
                    "measure": "Correlation between changes in LV stroke volume reserve at submaximal exercise and changes in pVO2",
                    "description": "Correlation between changes in LV stroke volume reserve at submaximal exercise and changes in pVO2 after catheter ablation.",
                    "timeFrame": "Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation."
                },
                {
                    "measure": "Correlation between baseline AF burden and LA function, LV Function and pVO2",
                    "description": "Correlation between baseline AF burden and LA function (rest and exercise), LV function (rest and exercise), and pVO2",
                    "timeFrame": "Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation."
                },
                {
                    "measure": "Correlation between the amount of AF burden reduction and the changes in LA function, LV function (rest and exercise), and pVO2.",
                    "description": "Correlation between the amount of AF burden reduction and the changes in LA function (rest and exercise), LV function (rest and exercise), and pVO2.",
                    "timeFrame": "Baseline and the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u226518 years\n* Diagnosis of paroxysmal AF\n* Left ventricular ejection fraction \u226550%\n* Scheduled for catheter ablation\n* Able to speak, hear, and read English\n* Willing and able to provide informed consent\n\nExclusion Criteria:\n\n* Persistent or permanent AF\n* Prior ablation (catheter based or surgical) for AF\n* Significant sinus node dysfunction\n* Implanted pacemaker or defibrillator\n* Contraindication to or inability to complete cardiovascular magnetic resonance study\n* Contraindication to or inability to complete exercise testing\n* Chronic kidney disease with estimated glomerular filtration rate \\<30 mL/min/1.73m2\n* Severe left ventricular hypertrophy\n* Unrelated cardiomyopathy that is expected to limit exercise capacity, including but not limited to:\n\n  * Hypertrophic cardiomyopathy\n  * Cardiac amyloidosis\n  * Constrictive pericarditis\n* Pulmonary arterial hypertension\n* Prior cardiac surgery\n* Active pregnancy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "In patients undergoing catheter ablation for paroxysmal AF, reduction or elimination of arrhythmia burden will result in favorable LA reverse remodeling - which will result in improved LA reservoir function reserve during exercise, thereby augmenting LV stroke volume reserve during exercise.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Pamela Grizzard",
                    "role": "CONTACT",
                    "phone": "804-628-6234",
                    "email": "pamela.grizzard@vcuhealth.org"
                },
                {
                    "name": "Melissa Sears",
                    "role": "CONTACT",
                    "phone": "804-828-1601",
                    "email": "melissa.sears@vcuhealth.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Cory Trankle",
                    "affiliation": "Virginia Commonwealth University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Virginia Commonwealth University",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23298",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Pamela Grizzard",
                            "role": "CONTACT",
                            "phone": "804-628-6234",
                            "email": "pamela.grizzard@vcuhealth.org"
                        },
                        {
                            "name": "Melissa Sears",
                            "role": "CONTACT",
                            "phone": "804-828-1601",
                            "email": "melissa.sears@vcuhealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001281",
                    "term": "Atrial Fibrillation"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001145",
                    "term": "Arrhythmias, Cardiac"
                },
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4586",
                    "name": "Atrial Fibrillation",
                    "asFound": "Atrial Fibrillation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4453",
                    "name": "Arrhythmias, Cardiac",
                    "relevance": "LOW"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}